WCLC 2025 - Posters & ePosters-P3.12.57 Phase I/II Study of FHND9041 in T790M-Positive Advanced NSCLC Patients Progressed After Prior EGFR-TKI Therapy

P3.12.57 Phase I/II Study of FHND9041 in T790M-Positive Advanced NSCLC Patients Progressed After Prior EGFR-TKI Therapy

Asset Subtitle

Dechuang Yuan

Meta Tag

Speaker Dechuang Yuan

Topic Metastatic Non-small Cell Lung Cancer – Targeted Therapy